The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Carbapenem Activities against Pseudomonas aeruginosa : Respective Contributions of OprD and Efflux Systems
Open accessAbstract
While meropenem MICs were strongly influenced by the presence or absence of the MexAB-OprM efflux pump in both OprD-proficient and -deficient strain backgrounds, MICs of imipenem and of ER-35786 remained unchanged, demonstrating that meropenem is a substrate of MexAB-OprM but not imipenem and ER-35786. In vitro, all three carbapenems selected loss of OprD as a first mechanism of resistance. However, in an OprD-deficient background, meropenem was able to select MexAB-OprM overproducers as a secondary resistance mechanism, while ER-35786 selected a mutant cross-resistant to sparfloxacin and cefpirome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Multidrug efflux pumps of gram-negative bacteria
Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.20.5853-5859.1996 · Cited by 1,082
Poole, K., Krebes, K., McNally, C., & Neshat, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7363-7372.1993 · Cited by 688
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa
Li, X. Z., Nikaido, H., & Poole, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1948 · Cited by 643
Ko¨hler, T., Michéa‐Hamzehpour, M., Henze, U., Gotoh, N., Kocjancic Curty, L., & Pechère, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
Self-citationPoole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Trias, J., & Nikaido, H. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.52 · Cited by 291
Li, X. Z., Ma, D., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1742 · Cited by 278
Ziha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J.-C., & Plesiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
Self-citation
Cited by
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Driscoll, J. A., Brody, S. L., & Kollef, M. H. (2007) · Drugs · doi:10.2165/00003495-200767030-00003 · Cited by 884
How to manage Pseudomonas aeruginosa infections
Bassetti, M., Vena, A., Croxatto, A., Righi, E., & Guery, B. (2018) · Drugs in Context · doi:10.7573/dic.212527 · Cited by 746
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Doi, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz830 · Cited by 652
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Hancock, R. E. W., & Speert, D. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0152 · Cited by 515
Khan, A. U., Maryam, L., & Zarrilli, R. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1012-8 · Cited by 512
Multidrug resistance mechanisms: drug efflux across two membranes
Zgurskaya, H. I., & Nikaido, H. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01926.x · Cited by 466
Zhanel, G. G., Golden, A. R., Zelenitsky, S., Wiebe, K., Lawrence, C. K., Adam, H. J., Idowu, T., Domalaon, R., Schweizer, F., Zhanel, M. A., et al. (2019) · Drugs · doi:10.1007/s40265-019-1055-2 · Cited by 446
Structure, function and regulation of Pseudomonas aeruginosa porins
Chevalier, S., Bouffartigues, E., Bodilis, J., Maillot, O., Lesouhaitier, O., Feuilloley, M. G. J., Orange, N., Dufour, A., & Cornelis, P. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux020 · Cited by 423
Quale, J., Bratu, S., Gupta, J., & Landman, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1633-1641.2006 · Cited by 409
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Self-citationOf Pseudomonas, porins, pumps and carbapenems
Livermore, D. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.247 · Cited by 391
Zhanel, G. G., Lawrence, C. K., Adam, H., Schweizer, F., Zelenitsky, S., Zhanel, M., Lagacé-Wiens, P. R. S., Walkty, A., Denisuik, A., Golden, A., et al. (2018) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 377
Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation
Kvist, M., Hancock, V., & Klemm, P. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01310-08 · Cited by 353
Detection of Pseudomonas aeruginosa Producing Metallo-β-Lactamases in a Large Centralized Laboratory
Pitout, J. D. D., Gregson, D. B., Poirel, L., McClure, J.-A., Le, P., & Church, D. L. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3129-3135.2005 · Cited by 331
Carbapenemases: a problem in waiting?
Livermore, D. M., & Woodford, N. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00128-4 · Cited by 323
Gales, A. C., Jones, R. N., Turnidge, J., Rennie, R., & Ramphal, R. (2001) · Clinical Infectious Diseases · doi:10.1086/320186 · Cited by 309
Köhler, T., Epp, S. F., Curty, L. K., & Pechère, J.-C. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.20.6300-6305.1999 · Cited by 302
Self-citationNew β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Drawz, S. M., Papp-Wallace, K. M., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00826-13 · Cited by 286
Denyer, S. P., & Maillard, J.-Y. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.19.x · Cited by 276
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
Livermore, D. M., Warner, M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt178 · Cited by 268
Li, H., Luo, Y.-F., Williams, B. J., Blackwell, T. S., & Xie, C.-M. (2012) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.10.001 · Cited by 266
Lee, A., Mao, W., Warren, M. S., Mistry, A., Hoshino, K., Okumura, R., Ishida, H., & Lomovskaya, O. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.11.3142-3150.2000 · Cited by 263
Mobile Carbapenemase Genes in Pseudomonas aeruginosa
Yoon, E.-J., & Jeong, S. H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.614058 · Cited by 221
Shaaban, M. I., Shaker, M. A., & Mady, F. M. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0262-9 · Cited by 58
Metadata
- Authors
- Köhler, T., Michea-Hamzehpour, M., Epp, S. F., & Pechere, J.-C.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1999-02
- Volume
- 43
- Issue
- 2
- Pages
- 424-427
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2166576226
- Cited by
- 268
- References
- 18
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.